HEADER OXIDOREDUCTASE 04-FEB-07 2ORQ TITLE MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) 4- TITLE 2 (IMIDAZOL-1-YL)PHENOL AND PIPERONYLAMINE COMPLEX COMPND MOL_ID: 1; COMPND 2 MOLECULE: NITRIC OXIDE SYNTHASE, INDUCIBLE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: OXYGENASE DOMAIN 114-498; COMPND 5 SYNONYM: NOS TYPE II, INDUCIBLE NO SYNTHASE, INDUCIBLE NOS, INOS, COMPND 6 MACROPHAGE NOS, MAC-NOS; COMPND 7 EC: 1.14.13.39; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: HOUSE MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 GENE: NOS2, INOSL; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: MACROPHAGE; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PCWORI KEYWDS NITRIC OXIDE, L-ARGININE MONOOXYGENASE, HEME, DIMERIZATION, KEYWDS 2 INHIBITOR, NOS, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR M.ADLER,M.WHITLOW REVDAT 3 21-FEB-24 2ORQ 1 REMARK SEQADV REVDAT 2 24-FEB-09 2ORQ 1 VERSN REVDAT 1 17-APR-07 2ORQ 0 JRNL AUTH D.D.DAVEY,M.ADLER,D.ARNAIA,K.EAGEN,S.ERICKSON,W.GUILFORD, JRNL AUTH 2 M.KENRICK,M.M.MORRISSEY,M.OHIMEYER,G.PAN,V.M.PARADKAR, JRNL AUTH 3 J.PARKINSON,M.POLOKOFF,K.SALONZ,C.SANTOS,B.SUBRAMANYAM, JRNL AUTH 4 R.VERGONA,R.G.WEI,M.WHITLOW,B.YE,Z.S.ZHAO,J.J.DEVLIN, JRNL AUTH 5 G.PHILLIPS JRNL TITL DESIGN, SYNTHESIS, AND ACTIVITY OF 2-IMIDAZOL-1-YLPYRIMIDINE JRNL TITL 2 DERIVED INDUCIBLE NITRIC OXIDE SYNTHASE DIMERIZATION JRNL TITL 3 INHIBITORS JRNL REF J.MED.CHEM. V. 50 1146 2007 JRNL REFN ISSN 0022-2623 JRNL PMID 17315988 JRNL DOI 10.1021/JM061319I REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.WHITLOW,M.ADLER,D.D.DAVEY,Q.HUANG,S.KOOVAKKAT,E.PHAM, REMARK 1 AUTH 2 M.POLOKOFF,W.XU,S.S.YUAN,G.PHILLIPS REMARK 1 TITL THE RATIONAL DESIGN OF INHIBITORS OF NITRIC OXIDE FORMATION REMARK 1 TITL 2 BY INDUCIBLE NITRIC OXIDE SYNTHASE REMARK 1 REF BIOORG.MED.CHEM.LETT. V. 17 2505 2007 REMARK 1 REFN ISSN 0960-894X REMARK 1 PMID 17336523 REMARK 1 DOI 10.1016/J.BMCL.2007.02.018 REMARK 1 REFERENCE 2 REMARK 1 AUTH R.G.WEI,M.ADLER,D.DAVEY,E.HO,R.MOHAN,M.POLOKOFF,J.L.TSENG, REMARK 1 AUTH 2 M.WHITLOW,W.XU,S.YUAN,G.PHILLIPS REMARK 1 TITL 3-[4-(1-IMIDAZOLYL)PHENOXY]-1-PIPERONYL PIPERIDINE ANALOGS REMARK 1 TITL 2 AS POTENT AND SELECTIVE INHIBITORS OF NITRIC OXIDE FORMATION REMARK 1 REF TO BE PUBLISHED 2007 REMARK 1 REFN REMARK 1 REFERENCE 3 REMARK 1 AUTH K.MCMILLAN,M.ADLER,D.S.AULD,J.J.BALDWIN,E.BLASKO,L.J.BROWNE, REMARK 1 AUTH 2 D.CHELSKY,D.DAVEY,R.E.DOLLE,K.A.EAGEN,S.ERICKSON, REMARK 1 AUTH 3 R.I.FELDMAN,C.B.GLASER,C.MALLARI,M.M.MORRISSEY,M.H.OHLMEYER, REMARK 1 AUTH 4 G.PAN,J.F.PARKINSON,G.B.PHILLIPS,M.A.POLOKOFF,N.H.SIGAL, REMARK 1 AUTH 5 R.VERGONA,M.WHITLOW,T.A.YOUNG,J.J.DEVLIN REMARK 1 TITL ALLOSTERIC INHIBITORS OF INDUCIBLE NITRIC OXIDE SYNTHASE REMARK 1 TITL 2 DIMERIZATION DISCOVERED VIA COMBINATORIAL CHEMISTRY. REMARK 1 REF PROC.NATL.ACAD.SCI.USA V. 97 1506 2000 REMARK 1 REFN ISSN 0027-8424 REMARK 1 PMID 10677491 REMARK 1 DOI 10.1073/PNAS.97.4.1506 REMARK 1 REFERENCE 4 REMARK 1 AUTH B.R.CRANE,A.S.ARVAI,R.GACHHUI,C.WU,D.K.GHOSH,E.D.GETZOFF, REMARK 1 AUTH 2 D.J.STUEHR,J.A.TAINER REMARK 1 TITL THE STRUCTURE OF NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN AND REMARK 1 TITL 2 INHIBITOR COMPLEXES. REMARK 1 REF SCIENCE V. 278 425 1997 REMARK 1 REFN ISSN 0036-8075 REMARK 1 PMID 9334294 REMARK 1 DOI 10.1126/SCIENCE.278.5337.425 REMARK 1 REFERENCE 5 REMARK 1 AUTH D.K.GHOSH,C.WU,E.PITTERS,M.MOLONEY,E.R.WERNER,B.MAYER, REMARK 1 AUTH 2 D.J.STUEHR REMARK 1 TITL CHARACTERIZATION OF THE INDUCIBLE NITRIC OXIDE SYNTHASE REMARK 1 TITL 2 OXYGENASE DOMAIN IDENTIFIES A 49 AMINO ACID SEGMENT REQUIRED REMARK 1 TITL 3 FOR SUBUNIT DIMERIZATION AND TETRAHYDROBIOPTERIN REMARK 1 TITL 4 INTERACTION. REMARK 1 REF BIOCHEMISTRY V. 36 10609 1997 REMARK 1 REFN ISSN 0006-2960 REMARK 1 PMID 9271491 REMARK 1 DOI 10.1021/BI9702290 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2005 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 1737277.560 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 25053 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.243 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 967 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 8 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.19 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 93.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2857 REMARK 3 BIN R VALUE (WORKING SET) : 0.2400 REMARK 3 BIN FREE R VALUE : 0.2880 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.10 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 123 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.026 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2439 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 66 REMARK 3 SOLVENT ATOMS : 167 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 24.00 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 37.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -5.94000 REMARK 3 B22 (A**2) : 6.92000 REMARK 3 B33 (A**2) : -0.98000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.22 REMARK 3 ESD FROM SIGMAA (A) : 0.17 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.28 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.20 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 0.800 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.80 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.760 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.530 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.520 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 2.450 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.730 ; 3.000 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.43 REMARK 3 BSOL : 83.69 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.P REMARK 3 PARAMETER FILE 2 : WATER_REP.PAR REMARK 3 PARAMETER FILE 3 : HEM.PAR REMARK 3 PARAMETER FILE 4 : PIM.PAR REMARK 3 PARAMETER FILE 5 : PPA.PAR REMARK 3 PARAMETER FILE 6 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : HEM.TOP REMARK 3 TOPOLOGY FILE 4 : PIM.TOP REMARK 3 TOPOLOGY FILE 5 : PPA.TOP REMARK 3 TOPOLOGY FILE 6 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 IN THE ACTIVE SITE THE POSITION OF GLU 371 AND HOH 603 ARE REMARK 3 MUTAULLY EXCLUSIVE WITH THE PARTIALLY OCCUPIED PIPERONYLAMINE (PPA) REMARK 3 . I WAS UNABLE TO REFINE BOTH SIMULTANEOUSLY SO THE PREVIOUSLY REMARK 3 REFINED PIPERONYLAMINE POSTION WAS ADDED TO THE FINAL REFINEMENT REMARK 3 WITH GLU 371. REMARK 3 ATOMS WITH NO 1.0 SIGMA 2FO-FC DENSITY HAD THEIR OCCUPANCY LOWERED REMARK 3 TO 0.5. THE POSITION OF THESE ATOMS SHOULD NOT BE TRUSTED. REMARK 4 REMARK 4 2ORQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-FEB-07. REMARK 100 THE DEPOSITION ID IS D_1000041503. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 12-FEB-99 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 4.70 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL9-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25450 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 24.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.2 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.06200 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.15 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.8 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.45500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.600 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: PDB ENTRY BX04 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: CRYSTALS OF MURINE DELTA114 INOS WERE REMARK 280 PREPARED IN THE PRESENCE OF IMIDAZOLE FOLLOWING THE PROCEDURES REMARK 280 OF CRANE ET AL. (REFERENCE 3) AS FOLLOWS: THE 6 UL REMARK 280 CRYSTALLIZATION DROPS CONTAINED 20 MG/ML MURINE DELTA114 INOS, REMARK 280 20 MM HEPES PH 7.6, 5 % GLYCEROL, 0.5 MM DTT, 6.8 % PEG-3350, 60 REMARK 280 MM NA2SO3, AND 50 MM IMIDAZOLE/ MALATE BUFFER PH 4.7 WERE PLACED REMARK 280 OVER A 1 ML RESERVOIR CONTAINING 13.6 % PEG-3350, 120 MM NA2SO3, REMARK 280 AND 100 MM IMIDAZOLE/MALATE BUFFER PH 4.7. THESE CRYSTALS WERE REMARK 280 SOAKED FOR 25 HOURS IN ?? UM 4-(IMIDAZOL-1-YL)PHENOL AND ?? UM REMARK 280 PIPERONYLAMINE, 14 % PEG-3350, 1 MM NAN3, 50 MM MES PH 6.5 AND REMARK 280 50 MM NA2SO3. THE, PH 4.70, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 308K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 31.49500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 46.34000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.08500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 46.34000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 31.49500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.08500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 31.49500 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 -37.08500 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 92.68000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 266 REMARK 465 GLU A 326 REMARK 465 HIS A 327 REMARK 465 PRO A 328 REMARK 465 LYS A 329 REMARK 465 TYR A 330 REMARK 465 GLU A 331 REMARK 465 TRP A 332 REMARK 465 PHE A 333 REMARK 465 GLN A 334 REMARK 465 GLU A 335 REMARK 465 ILE A 372 REMARK 465 GLY A 373 REMARK 465 VAL A 374 REMARK 465 ARG A 375 REMARK 465 ASP A 376 REMARK 465 PHE A 377 REMARK 465 CYS A 378 REMARK 465 ASP A 379 REMARK 465 THR A 380 REMARK 465 GLN A 381 REMARK 465 ARG A 382 REMARK 465 TYR A 383 REMARK 465 ASN A 384 REMARK 465 ILE A 385 REMARK 465 LEU A 386 REMARK 465 GLU A 387 REMARK 465 GLU A 388 REMARK 465 VAL A 389 REMARK 465 GLY A 390 REMARK 465 ARG A 391 REMARK 465 ARG A 392 REMARK 465 MET A 393 REMARK 465 GLY A 394 REMARK 465 LEU A 395 REMARK 465 GLU A 396 REMARK 465 THR A 397 REMARK 465 HIS A 398 REMARK 465 THR A 399 REMARK 465 LEU A 400 REMARK 465 ALA A 401 REMARK 465 SER A 402 REMARK 465 LEU A 403 REMARK 465 TRP A 404 REMARK 465 LYS A 405 REMARK 465 ASP A 406 REMARK 465 ARG A 407 REMARK 465 ALA A 408 REMARK 465 VAL A 409 REMARK 465 THR A 410 REMARK 465 GLU A 411 REMARK 465 ILE A 412 REMARK 465 ARG A 446 REMARK 465 ALA A 447 REMARK 465 ARG A 448 REMARK 465 GLY A 449 REMARK 465 GLY A 450 REMARK 465 CYS A 451 REMARK 465 PRO A 452 REMARK 465 ALA A 453 REMARK 465 ASP A 454 REMARK 465 TRP A 455 REMARK 465 ILE A 456 REMARK 465 TRP A 457 REMARK 465 LEU A 458 REMARK 465 VAL A 459 REMARK 465 PRO A 460 REMARK 465 PRO A 461 REMARK 465 VAL A 462 REMARK 465 SER A 463 REMARK 465 GLY A 464 REMARK 465 SER A 465 REMARK 465 ILE A 466 REMARK 465 THR A 467 REMARK 465 PRO A 468 REMARK 465 VAL A 469 REMARK 465 PHE A 470 REMARK 465 HIS A 471 REMARK 465 GLN A 472 REMARK 465 GLU A 473 REMARK 465 MET A 474 REMARK 465 LEU A 475 REMARK 465 ASN A 476 REMARK 465 TYR A 477 REMARK 465 GLU A 498 REMARK 465 HIS A 499 REMARK 465 HIS A 500 REMARK 465 HIS A 501 REMARK 465 HIS A 502 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 445 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 149 -102.01 54.96 REMARK 500 SER A 245 -90.78 -100.62 REMARK 500 ARG A 292 -169.73 -74.29 REMARK 500 TYR A 293 38.22 -143.69 REMARK 500 CYS A 361 66.91 -159.14 REMARK 500 GLU A 444 98.04 -63.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 HEM A 600 FE REMARK 620 N RES CSSEQI ATOM REMARK 620 1 CYS A 194 SG REMARK 620 2 HEM A 600 NA 92.3 REMARK 620 3 HEM A 600 NB 86.8 89.8 REMARK 620 4 HEM A 600 NC 89.2 178.1 91.4 REMARK 620 5 HEM A 600 ND 92.7 88.8 178.5 90.0 REMARK 620 6 MSR A 601 NFE 175.6 90.3 89.6 88.2 90.9 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE HEM A 600 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MSR A 601 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MR1 A 602 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1DD7 RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 (N-[(1,3-BENZODIOXOL-5-YL)METHYL]-1-[2-(1H-IMIDAZOL-1-YL)PYRIMIDIN- REMARK 900 4-YL]-4-(METHOXYCARBONYL)-PIPERAZINE-2-ACETAMIDE COMPLEX REMARK 900 RELATED ID: 2ORO RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 (R)-1-(2-IMIDAZOL-1-YL-6-METHYL-PYRIMIDIN-4-YL)-PYRROLIDINE-2- REMARK 900 CARBOXYLIC ACID (2-BENZO[1,3]DIOXOL-5-YL-ETHYL)-AMIDE COMPLEX REMARK 900 RELATED ID: 2ORP RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 2-[4-(2-IMIDAZOL-1-YL-6-METHYL-PYRIMIDIN-4-YL)-1-ISOBUTYRYL- REMARK 900 PIPERAZIN-2-YL]-N-[2-(4-METHOXY-PHENYL)-ETHYL]-ACETAMIDE COMPLEX REMARK 900 RELATED ID: 2ORR RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 4-(BENZO[1,3]DIOXOL-5-YLOXY)-2-(4-IMIDAZOL-1-YL -PHENOXY)- REMARK 900 PYRIMIDINE COMPLEX REMARK 900 RELATED ID: 2ORS RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 4-(BENZO[1,3]DIOXOL-5-YLOXY)-2-(4-IMIDAZOL-1-YL -PHENOXY)-6-METHYL- REMARK 900 PYRIMIDINE COMPLEX REMARK 900 RELATED ID: 2ORT RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 1-BENZO[1,3]DIOXOL-5-YLMETHYL-3S-(4-IMIDAZOL-1- YL-PHENOXY)- REMARK 900 PIPERIDINE COMPLEX REMARK 900 RELATED ID: 1NOS RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 IMIDIZOLE COMPLEX REMARK 900 RELATED ID: 1NOC RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114) REMARK 900 COMPLEXED WITH TYPE I E. COLI CHLORAMPHENICOL ACETYL TRANSFERASE REMARK 900 AND IMIDAZOLE REMARK 900 RELATED ID: 1NOD RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DIMER (DELTA 65) REMARK 900 WITH TETRAHYDROBIOPTERIN AND SUBSTRATE L-ARGININE REMARK 900 RELATED ID: 2NOS RELATED DB: PDB REMARK 900 MURINE INDUCIBLE NITRIC OXIDE SYNTHASE OXYGENASE DOMAIN (DELTA 114), REMARK 900 AMINOGUANIDINE COMPLEX REMARK 900 RELATED ID: 1NSI RELATED DB: PDB REMARK 900 HUMAN INDUCIBLE NITRIC OXIDE SYNTHASE, ZN-BOUND, L-ARG COMPLEX DBREF 2ORQ A 114 498 UNP P29477 NOS2_MOUSE 114 498 SEQADV 2ORQ HIS A 499 UNP P29477 EXPRESSION TAG SEQADV 2ORQ HIS A 500 UNP P29477 EXPRESSION TAG SEQADV 2ORQ HIS A 501 UNP P29477 EXPRESSION TAG SEQADV 2ORQ HIS A 502 UNP P29477 EXPRESSION TAG SEQRES 1 A 389 MET ASN PRO LYS SER LEU THR ARG GLY PRO ARG ASP LYS SEQRES 2 A 389 PRO THR PRO LEU GLU GLU LEU LEU PRO HIS ALA ILE GLU SEQRES 3 A 389 PHE ILE ASN GLN TYR TYR GLY SER PHE LYS GLU ALA LYS SEQRES 4 A 389 ILE GLU GLU HIS LEU ALA ARG LEU GLU ALA VAL THR LYS SEQRES 5 A 389 GLU ILE GLU THR THR GLY THR TYR GLN LEU THR LEU ASP SEQRES 6 A 389 GLU LEU ILE PHE ALA THR LYS MET ALA TRP ARG ASN ALA SEQRES 7 A 389 PRO ARG CYS ILE GLY ARG ILE GLN TRP SER ASN LEU GLN SEQRES 8 A 389 VAL PHE ASP ALA ARG ASN CYS SER THR ALA GLN GLU MET SEQRES 9 A 389 PHE GLN HIS ILE CYS ARG HIS ILE LEU TYR ALA THR ASN SEQRES 10 A 389 ASN GLY ASN ILE ARG SER ALA ILE THR VAL PHE PRO GLN SEQRES 11 A 389 ARG SER ASP GLY LYS HIS ASP PHE ARG LEU TRP ASN SER SEQRES 12 A 389 GLN LEU ILE ARG TYR ALA GLY TYR GLN MET PRO ASP GLY SEQRES 13 A 389 THR ILE ARG GLY ASP ALA ALA THR LEU GLU PHE THR GLN SEQRES 14 A 389 LEU CYS ILE ASP LEU GLY TRP LYS PRO ARG TYR GLY ARG SEQRES 15 A 389 PHE ASP VAL LEU PRO LEU VAL LEU GLN ALA ASP GLY GLN SEQRES 16 A 389 ASP PRO GLU VAL PHE GLU ILE PRO PRO ASP LEU VAL LEU SEQRES 17 A 389 GLU VAL THR MET GLU HIS PRO LYS TYR GLU TRP PHE GLN SEQRES 18 A 389 GLU LEU GLY LEU LYS TRP TYR ALA LEU PRO ALA VAL ALA SEQRES 19 A 389 ASN MET LEU LEU GLU VAL GLY GLY LEU GLU PHE PRO ALA SEQRES 20 A 389 CYS PRO PHE ASN GLY TRP TYR MET GLY THR GLU ILE GLY SEQRES 21 A 389 VAL ARG ASP PHE CYS ASP THR GLN ARG TYR ASN ILE LEU SEQRES 22 A 389 GLU GLU VAL GLY ARG ARG MET GLY LEU GLU THR HIS THR SEQRES 23 A 389 LEU ALA SER LEU TRP LYS ASP ARG ALA VAL THR GLU ILE SEQRES 24 A 389 ASN VAL ALA VAL LEU HIS SER PHE GLN LYS GLN ASN VAL SEQRES 25 A 389 THR ILE MET ASP HIS HIS THR ALA SER GLU SER PHE MET SEQRES 26 A 389 LYS HIS MET GLN ASN GLU TYR ARG ALA ARG GLY GLY CYS SEQRES 27 A 389 PRO ALA ASP TRP ILE TRP LEU VAL PRO PRO VAL SER GLY SEQRES 28 A 389 SER ILE THR PRO VAL PHE HIS GLN GLU MET LEU ASN TYR SEQRES 29 A 389 VAL LEU SER PRO PHE TYR TYR TYR GLN ILE GLU PRO TRP SEQRES 30 A 389 LYS THR HIS ILE TRP GLN ASN GLU HIS HIS HIS HIS HET HEM A 600 43 HET MSR A 601 12 HET MR1 A 602 11 HETNAM HEM PROTOPORPHYRIN IX CONTAINING FE HETNAM MSR 4-(1H-IMIDAZOL-1-YL)PHENOL HETNAM MR1 1-(1,3-BENZODIOXOL-5-YL)METHANAMINE HETSYN HEM HEME FORMUL 2 HEM C34 H32 FE N4 O4 FORMUL 3 MSR C9 H8 N2 O FORMUL 4 MR1 C8 H9 N O2 FORMUL 5 HOH *167(H2 O) HELIX 1 1 PRO A 129 SER A 147 1 19 HELIX 2 2 LYS A 152 GLY A 171 1 20 HELIX 3 3 THR A 176 ASN A 190 1 15 HELIX 4 4 CYS A 194 TRP A 200 5 7 HELIX 5 5 THR A 213 ASN A 230 1 18 HELIX 6 6 ASN A 231 ASN A 233 5 3 HELIX 7 7 THR A 277 LEU A 287 1 11 HELIX 8 8 PRO A 316 VAL A 320 5 5 HELIX 9 9 ASN A 413 GLN A 423 1 11 HELIX 10 10 ASP A 429 GLU A 444 1 16 HELIX 11 11 GLU A 488 THR A 492 5 5 SHEET 1 A 4 GLN A 204 ASP A 207 0 SHEET 2 A 4 ALA A 237 VAL A 240 1 O ILE A 238 N PHE A 206 SHEET 3 A 4 PHE A 363 ASN A 364 -1 O ASN A 364 N ALA A 237 SHEET 4 A 4 ALA A 345 VAL A 346 -1 N VAL A 346 O PHE A 363 SHEET 1 B 3 ARG A 252 LEU A 253 0 SHEET 2 B 3 LEU A 301 GLN A 304 -1 O GLN A 304 N ARG A 252 SHEET 3 B 3 GLU A 311 PHE A 313 -1 O PHE A 313 N LEU A 301 SHEET 1 C 2 GLY A 263 TYR A 264 0 SHEET 2 C 2 ARG A 272 GLY A 273 -1 O ARG A 272 N TYR A 264 SHEET 1 D 2 GLU A 322 THR A 324 0 SHEET 2 D 2 LYS A 339 TYR A 341 -1 O TRP A 340 N VAL A 323 SHEET 1 E 3 LEU A 356 PHE A 358 0 SHEET 2 E 3 LEU A 350 VAL A 353 -1 N LEU A 351 O PHE A 358 SHEET 3 E 3 PHE A 482 TYR A 484 -1 O TYR A 484 N LEU A 350 LINK SG CYS A 194 FE HEM A 600 1555 1555 2.17 LINK FE HEM A 600 NFE MSR A 601 1555 1555 2.31 CISPEP 1 SER A 480 PRO A 481 0 -2.26 SITE 1 AC1 15 TRP A 188 ARG A 193 CYS A 194 ILE A 195 SITE 2 AC1 15 GLY A 196 GLN A 199 SER A 236 PHE A 363 SITE 3 AC1 15 ASN A 364 GLY A 365 TRP A 366 MET A 368 SITE 4 AC1 15 TYR A 483 TYR A 485 MSR A 601 SITE 1 AC2 6 GLN A 257 PRO A 344 VAL A 346 GLY A 365 SITE 2 AC2 6 HEM A 600 MR1 A 602 SITE 1 AC3 4 TRP A 366 TYR A 367 MET A 368 MSR A 601 CRYST1 62.990 74.170 92.680 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015876 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010790 0.00000